Benefits Far Outweigh Risks: Expert on Rare Covishield Side Effect

Former ICMR scientist Dr. Raman Gangakhedkar has said that only a small fraction of individuals, approximately seven to eight out of every 10 lakh recipients of the Covishield vaccine, are at risk of encountering a rare side effect called thrombosis thrombocytopenia syndrome (TTS). Gangakhedkar reassured that for those who have received this vaccine, the risk is virtually non-existent.